Holen Sie sich die Stockscreener-App
42.03
18.33%
6.51
Handel nachbörslich:
42.90
0.87
+2.07%
Schlusskurs vom Vortag:
$35.52
Offen:
$43.37
24-Stunden-Volumen:
2.59M
Relative Volume:
3.72
Marktkapitalisierung:
$1.47B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+14.00%
1M Leistung:
+162.20%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$39.60
$46.45
1-Wochen-Bereich:
$34.72
$46.45
52-Wochen-Spanne:
$14.72
$46.45
First Tracks Biotherapeutics Inc Stock (TRAX) Company Profile
Firmenname
First Tracks Biotherapeutics Inc
Sektor
Branche
Telefon
212-373-3000
Adresse
10770 WATERIDGE CIRCLE, SAN DIEGO
Compare TRAX vs VRTX, REGN, ARGX, RVMD, ALNY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRAX
First Tracks Biotherapeutics Inc
|
42.03 | 1.24B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
First Tracks Biotherapeutics Inc Stock (TRAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-24 | Eingeleitet | Leerink Partners | Outperform |
| 2026-04-24 | Eingeleitet | Wedbush | Outperform |
| 2026-04-23 | Eingeleitet | JP Morgan | Overweight |
| 2026-04-22 | Eingeleitet | Barclays | Overweight |
| 2026-04-21 | Eingeleitet | UBS | Buy |
First Tracks Biotherapeutics Inc Aktie (TRAX) Neueste Nachrichten
First Tracks Biotherapeutics: Buy Rating Reaffirmed with Unchanged $44 Price Target on ANB033 CD122-Targeting Upside and Acquisition Potential - TipRanks
After Forte acquisition, H.C. Wainwright says First Tracks could be target - TipRanks
TRAX Stock Volatile As Traders Focus On Cash And Momentum - StocksToTrade
Wedbush Adjusts First Tracks Biotherapeutics Price Target to $60 From $30, Maintains Outperform Rating - marketscreener.com
Let's uncover which stocks are experiencing notable gaps during today's session. - ChartMill
These stocks that are showing activity before the opening bell on Monday. - ChartMill
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Anaptysbio, Inc Net Worth (2026) - GuruFocus
Which stocks are moving before the opening bell on Thursday? - ChartMill
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
First Tracks Biotherapeutics Ord Shs (TRAX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
Piper Sandler Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $54 - Moomoo
TRAX Stock Hits All-Time High — What's Driving The Super Rally? - Stocktwits
First Tracks Biotherapeutics (TRAX) Stock Forum and Discussion - Moomoo
First Tracks Biotherapeutics Inc. (TRAX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
First Tracks Biotherapeutics (TRAX) News Flow - Moomoo
Wells Fargo Reaffirms Their Buy Rating on First Tracks Biotherapeutics Inc (TRAX) - The Globe and Mail
XPEV Stock Rises 1.5% As CEO Takes First Robotaxi Ride In Guangzhou - Stocktwits
Meta, Moderna among market cap stock movers on Friday By Investing.com - Investing.com Australia
TRAX Stock Surges As Traders Pile Into Biotech Momentum - timothysykes.com
Lithium Americas Corp. (LAC) Stock Price | Live Quotes & Charts | NYSE - timothysykes.com
Meta, Moderna among market cap stock movers on Friday - Investing.com UK
First Tracks Biotherapeutics price target raised to $44 from $30 at H.C. Wainwright - TipRanks
Aehr Test Systems, Lam Research, Applied Materials And Other Big Stocks Moving Higher On Thursday - Sahm
TRAX Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart - mexc.co
J.P. Morgan Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Biotech Stocks At 52-Week Highs: TRAX, BBIO, MNPR, TXG, MPLT - RTTNews
H.C. Wainwright Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Raises Target Price to $44 - Moomoo
Wells Fargo Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Barclays Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $40 - Moomoo
Market Movers | Winners: FBRX, TRAX, CIRC | Losers: BYRN, RXT, AEON - Trefis
TRAX Stock Explodes Higher As Traders Pile Into Momentum - timothysykes.com
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Forte, First Tracks soar on CD122 success in vitiligo; celiac next - BioWorld News
H.C. Wainwright reiterates First Tracks stock Buy rating at $30 By Investing.com - Investing.com Canada
TRAX Reiterated by First Tracks -- Price Target Maintained at $3 - GuruFocus
Is AnaptysBio’s (ANAB) Index Exit and Office Sublease Quietly Reframing Its Strategic Focus? - simplywall.st
First Tracks Biotherapeutics, Inc.(NasdaqGS:TRAX) added to Russell Microcap Value Benchmark Index - marketscreener.com
First Tracks Biotherapeutics, Inc.(NasdaqGS:TRAX) added to Russell 2000 Value Benchmark - marketscreener.com
First Tracks Biotherapeutics, Inc.(NasdaqGS:TRAX) added to Russell 2500 Value Benchmark - marketscreener.com
TRAX Forecast — Price Target — Prediction for 2027 - TradingView
The Nasdaq Biotechnology Index closed up more than 1.52%. Among its constituents, Absci surged 35.96%, Silence Therapeutics rose 26.00%, and Aardvark Therapeutics, Definium Therapeutics, Black Diamond, Personalis, and Adaptive Biotechnologies gai - Bitget
AnaptysBio Subleases San Diego Facility to First Tracks - The Globe and Mail
First Tracks Biotherapeutics (NASDAQ: TRAX) subleases 45,057 sq ft in San Diego - Stock Titan
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Finanzdaten der First Tracks Biotherapeutics Inc-Aktie (TRAX)
Es liegen keine Finanzdaten für First Tracks Biotherapeutics Inc (TRAX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):